This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of targeted cancer therapies, particularly in the development of tyrosine kinase inhibitors. These inhibitors are designed to block specific enzymes involved in the growth and proliferation of cancer cells, making it a valuable component in the creation of drugs for treating various types of cancers, such as lung, breast, and colorectal cancer. Additionally, its structural properties make it a candidate for further modification to enhance its efficacy and selectivity in inhibiting tumor growth. Researchers also explore its potential in combination therapies to improve treatment outcomes and reduce resistance in cancer patients.